AbelZeta Pharma

Publications and Presentations

EVENT DATE SUBJECT
Annual J.P. Morgan Healthcare Conference January 10, 2024 Corporate Presentation and Clinical Trial Updates
ASH Annual Meeting & Exposition December 11, 2023

C-CAR039, a Novel Anti-CD20/CD19 Bi-Specific CAR T-Cell Therapy Shows Deep and Durable Clinical Benefits in Patients with Relapsed or Refractory (r/r) B-Cell Non-Hodgkin Lymphoma (B-NHL) in Long Term Follow up

Oral Presentation Abstract

Presentation Slides

December 9, 2023

Two-Year Follow-up Results of C-CAR066, a Novel Anti-CD20 Chimeric Antigen Receptor Cell Therapy (CAR-T) in Relapsed or Refractory (r/r) Large B-Cell Lymphoma (LBCL) Patients after Failure of CD19 CAR-T Therapy

Poster Presentation Abstract

Poster

AACR Annual Meeting April 14, 2023

First report of preliminary safety, efficacy, and pharmacokinetics of C-CAR031 (GPC3-specific TGFβRIIDN CAR-T) in patients with advanced HCC

Poster Presentation Abstract

Poster

Journal for Immunotherapy of Cancer September, 2022

Phase 1 study of C-CAR088, a novel humanized anti-BCMA CAR T-cell therapy in relapsed/refractory multiple myeloma

Abstract

Scroll to Top